Mapping the ligand binding site of the NK-1 receptor. 1993

T M Fong, and R R Huang, and H Yu, and C D Strader
Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, NJ 07065.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015288 Neurokinin A A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI. Substance K,Neurokinin alpha,Neuromedin L
D017384 Sequence Deletion Deletion of sequences of nucleic acids from the genetic material of an individual. Deletion Mutation,Deletion Mutations,Deletion, Sequence,Deletions, Sequence,Mutation, Deletion,Mutations, Deletion,Sequence Deletions
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D018041 Receptors, Neurokinin-2 A class of cell surface receptors for tachykinins that prefers neurokinin A; (NKA, substance K, neurokinin alpha, neuromedin L), neuropeptide K; (NPK); or neuropeptide gamma over other tachykinins. Neurokinin-2 (NK-2) receptors have been cloned and are similar to other G-protein coupled receptors. NK-2 Receptors,Neurokinin A Receptors,Neurokinin-2 Receptors,Receptors, NK-2,Receptors, Substance K,SP-K Receptors,Substance K Receptors,NK-2 Receptor,NK-2 Receptor Site,Neurokinin-2 Receptor,SP-K Receptor,Substance K Receptor,NK 2 Receptor,NK 2 Receptor Site,NK 2 Receptors,Neurokinin 2 Receptor,Neurokinin 2 Receptors,Receptor Site, NK-2,Receptor, NK-2,Receptor, Neurokinin-2,Receptor, SP-K,Receptor, Substance K,Receptors, NK 2,Receptors, Neurokinin 2,Receptors, Neurokinin A,Receptors, SP-K,SP K Receptor,SP K Receptors

Related Publications

T M Fong, and R R Huang, and H Yu, and C D Strader
April 1998, Proceedings of the National Academy of Sciences of the United States of America,
T M Fong, and R R Huang, and H Yu, and C D Strader
May 2002, The Journal of biological chemistry,
T M Fong, and R R Huang, and H Yu, and C D Strader
March 1995, Nature,
T M Fong, and R R Huang, and H Yu, and C D Strader
February 1995, Biochemical Society transactions,
T M Fong, and R R Huang, and H Yu, and C D Strader
November 2001, Biochemistry,
T M Fong, and R R Huang, and H Yu, and C D Strader
September 2006, Molecular pharmacology,
T M Fong, and R R Huang, and H Yu, and C D Strader
December 2000, Journal of immunology (Baltimore, Md. : 1950),
T M Fong, and R R Huang, and H Yu, and C D Strader
February 1988, Trends in pharmacological sciences,
T M Fong, and R R Huang, and H Yu, and C D Strader
February 1995, The Journal of biological chemistry,
T M Fong, and R R Huang, and H Yu, and C D Strader
February 2022, Proteins,
Copied contents to your clipboard!